SCHEMBL3473120

SCHEMBL3473120

Oc1ccc2ccccc2c1Cn1ccnc1

nearest known ligand 0.60

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
POLB P06746 3/20 0.60
KDM4E B2RXH2 7/20 0.53
MAPT P10636 7/20 0.53
TDP1 Q9NUW8 3/20 0.53
BRD4 O60885 2/20 0.53
LMNA P02545 1/20 0.53
L3MBTL1 Q9Y468 1/20 0.53
ALDH1A1 P00352 5/20 0.52
GAA P10253 4/20 0.52
CYP19A1 P11511 4/20 0.52
CYP1A2 P05177 2/20 0.51
CYP2C9 P11712 1/20 0.51
CYP2C19 P33261 1/20 0.51
HSD17B10 Q99714 1/20 0.51
CRHBP P24387 1/20 0.51
CRHR2 Q13324 1/20 0.51
TBXAS1 P24557 3/20 0.49
KMT2A Q03164 3/20 0.49
MEN1 O00255 1/20 0.49
SMN1; SMN2 Q16637 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11010710 0.82 POLB (0.60) POLBMAPTCYP19A1CYP1A2TBXAS1
SCHEMBL27705085 0.81 POLB (0.62) POLBMAPTCYP19A1CYP1A2TBXAS1
SCHEMBL11009610 0.79 CYP19A1 (0.59) POLBMAPTLMNAALDH1A1CYP19A1
SCHEMBL13907298 0.79 CYP11B1 (0.63) POLBMAPTCYP19A1CYP1A2TBXAS1
SCHEMBL8866026 0.75 POLB (1.00) POLBKDM4EMAPTTDP1BRD4
Oxalic Acid SCHEMBL11010176 0.71 POLB (0.83) POLBCYP19A1TBXAS1CYP11B1CYP11B2
SCHEMBL2341100 0.71 MAPT (0.54) KDM4EMAPTTDP1ALDH1A1GAA
SCHEMBL8050377 0.71 CYP11B1 (0.65) POLBKDM4EMAPTTDP1BRD4
SCHEMBL25239888 0.71 IDO1 (0.51) POLBKDM4EMAPTTDP1LMNA
SCHEMBL13105237 0.71 CYP11B1 (0.72) POLBMAPTCYP19A1CYP1A2TBXAS1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 30 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
JP-9118741-A None JP disclosed
US-11767450-B2 Adhesive, die attach film and preparation method therefor WUHAN CHOICE TECHNOLOGY CO, LTD (CN) 2023-09-26 US disclosed
US-20230265322-A1 ADHESIVE, DIE ATTACH FILM AND PREPARATION METHOD THEREFOR WUHAN CHOICE TECHNOLOGY CO,LTD (CN) 2023-08-24 US disclosed
CN-113897163-B Adhesive, chip bonding film and preparation method thereof 武汉市三选科技有限公司 2022-03-11 CN disclosed
CN-113897163-A Adhesive, chip bonding film and preparation method thereof 武汉市三选科技有限公司 2022-01-07 CN disclosed
US-7858713-B2 Accelerator systems for low-temperature curing HUNTSMAN ADVANCED MATERIALS AMERICAS INC. (US) 2010-12-28 US disclosed
US-7468441-B2 1-imidazolymethyl-substituted-2-naphtols and their use as accelerators for low-temperature curing HUNSTMAN ADVANCED MATERIALS AMERICAS INC. (US) 2008-12-23 US disclosed
US-20070100114-A1 Accelerator systems for low-temperature curing HUNTSMAN ADVANCED MATERIALS AMERICAS INC. (N/K/A HUNTSMAN ADVANCED MATERIALS AMERICAS LLC) 2007-05-03 US disclosed
EP-1613680-B1 ACCELERATOR SYSTEMS FOR LOW-TEMPERATURE CURING OF EPOXY RESIN COMPOSITIONS HUNTSMAN ADV MAT SWITZERLAND (CH) 2006-11-29 EP disclosed
US-20060211845-A1 1-Imidazolymethyl -substituted -2-naphtols and their use as accelerators for low - temperature curing HUNTSMAN ADVANCED MATERIALS AMERICAS INC. (US) 2006-09-21 US disclosed
EP-0761709-A2 1-Imidazolylmethyl-2-naphthols as catalysts for curing epoxy resins Ciba SC Holding AG (CH) 1997-03-12 EP disclosed
EP-0761709-A2 1-Imidazolylmethyl-2-naphthols as catalysts for curing epoxy resins Ciba SC Holding AG (CH) 1997-03-12 EP disclosed
EP-0761709-A2 1-Imidazolylmethyl-2-naphthols as catalysts for curing epoxy resins Ciba SC Holding AG (CH) 1997-03-12 EP disclosed
US-5591811-A SHELF LIFE, IMPROVED MECHANICAL PROPERTIES, FAST CURING CIBA-GEIGY CORPORATION (US) 1997-01-07 US disclosed
US-5591811-A SHELF LIFE, IMPROVED MECHANICAL PROPERTIES, FAST CURING CIBA-GEIGY CORPORATION (US) 1997-01-07 US disclosed
US-5591811-A SHELF LIFE, IMPROVED MECHANICAL PROPERTIES, FAST CURING CIBA-GEIGY CORPORATION (US) 1997-01-07 US disclosed
US-4528195-A Imidazole derivatives and salts thereof, their synthesis and intermediates and pharmaceutical formulations THOROGOOD PETER B (GB) 1985-07-09 US disclosed
EP-0003560-B1 IMIDAZOLE DERIVATIVES AND SALTS THEREOF, THEIR SYNTHESIS, AND PHARMACEUTICAL FORMULATIONS THE WELLCOME FOUNDATION LIMITED (GB) 1984-05-02 EP disclosed
US-4416895-A ANTICOAGULANTS, ANTISHOCK AGENTS BURROUGHS WELLCOME CO. (US) 1983-11-22 US disclosed
EP-0003560-A2 Imidazole derivatives and salts thereof, their synthesis, and pharmaceutical formulations THE WELLCOME FOUNDATION LIMITED (GB) 1979-08-22 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060211845-A1 1-Imidazolymethyl -substituted -2-naphtols and their use as accelerators for low - temperature curing NOP2, LMNA, RPL39 POLB 2173/4885KDM4E 944/4885MAPT 2659/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.